Tuberculosis

GHPC has closely examined TB epidemiology; U.S. and international approaches to combating global TB; drug-resistant TB and broader issues of antimicrobial resistance; the need to develop a more effective TB vaccine; as well as health system strengthening efforts including affordable access and models of delivery of new drugs

Tuberculosis (TB) is the number one infectious disease killer worldwide and is the leading cause of death for people living with HIV. Multidrug-resistant TB (MDR-TB) continues to pose a serious threat to health security, with the WHO estimating almost 480,000 cases of MDR-TB in 2019. Extensively drug-resistant TB (XDR-TB) poses health security risks.

There has been increasing recognition of the need for new drugs, diagnostics, vaccines, and tools to enhance infection control, surveillance, and access and adherence to TB treatment. Global focus, such as at the UN High-Level Meeting on Tuberculosis in 2018, has highlighted TB as an urgent health security priority.

GHPC has closely examined TB epidemiology; U.S. and international approaches to combating global TB; drug-resistant TB and broader issues of antimicrobial resistance; the need to develop a more effective TB vaccine; as well as health system strengthening efforts including affordable access and models of delivery of new drugs.

Featured Podcast

Pandemic Planet

Adrian Thomas of J&J on Tuberculosis and Covid-19

March 24, 2021 | Podcast Episode by Katherine E. Bliss , and J. Stephen Morrison

To mark World TB Day, Katherine E. Bliss and J. Stephen Morrison speak with Adrian Thomas, TB expert and leader of global strategy at Johnson & Johnson Global Health.

Listen to the podcast

All Tuberculosis Content

Filter by

1 - 10 of 64 results

The U.S. Government and Antimicrobial Resistance

Antimicrobial resistance (AMR) is a slow-moving epidemic that kills hundreds of thousands annually. The COVID-19 pandemic will worsen the problem. The U.S. government should take immediate action to mitigate the threat posed by AMR domestically and globally.

Report by Nellie Bristol — June 9, 2020

Coronavirus Crisis Update

Putin and Global Health: Friend or Foe?

Jeff Mankoff and Judyth Twigg join J. Stephen Morrison to discuss their recent analysis, "Putin and Global Health: Friend or Foe?"

Podcast Episode by J. Stephen Morrison and Judyth Twigg — October 2, 2019

CSIS Coronavirus Crisis Update
AIDS’ Existential Moment

Eric Goosby: HIV in San Francisco, Then and Now

​In this episode, Steve Morrison and Andrew Schwartz speak with Dr. Eric Goosby, UN Special Envoy on Tuberculosis.

Podcast Episode by J. Stephen Morrison, Sara M. Allinder, and H. Andrew Schwartz — July 25, 2019

CSIS AIDS Existential Moment
Coronavirus Crisis Update

Heads of State Meet for Historic UNGA High-Level Meeting on Tuberculosis

Tuberculosis (TB) is a long-standing, urgent threat to global public health, yet it has never been discussed at the highest level of the world stage. That changes this week, as heads of state gather in New York for the UN General Assembly, where they will convene the first-ever UNGA high-level meeting on tuberculosis.

Podcast Episode by J. Stephen Morrison — September 21, 2018

CSIS Coronavirus Crisis Update

Protecting the United States from the Health Security Risk of Global Tuberculosis

Tuberculosis (TB), an airborne infectious disease caused by the bacterium Mycobacterium tuberculosis, is the number one infectious disease killer in the world and among the top 10 causes of death worldwide.2 Moreover, numbers of drug-resistant forms of TB, currently 5 percent of global TB cases, are rapidly rising, posing a health security threat to the United States and the world. Cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are difficult and costly to treat, and are often fatal. Epidemics of MDR-TB and XDR-TB can originate within U.S. communities or spread from other countries. To be effective in protecting Americans from a costly and potentially deadly disease, the U.S. government must address TB and drug-resistant TB both domestically and globally.

Report by Audrey Jackson — July 5, 2017